Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus - a systematic review

Clinical and Experimental Allergy

Volumn 46, Issue 2, 2016, Pages 275-287

  Kolkhir, P ^a   Pogorelov, D ^a   Olisova, O ^a   Maurer, M ^b  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADULT; ARTICLE; AUTOIMMUNITY; BLOOD CLOTTING; CHILD; CHRONIC URTICARIA; COMORBIDITY; COMPLEMENT ACTIVATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; URTICARIA; CHRONIC DISEASE; COMPLICATION; LUPUS ERYTHEMATOSUS, SYSTEMIC;

CHRONIC DISEASE; COMORBIDITY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREVALENCE; URTICARIA;

EID: 84955606693     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12673     Document Type: Article

References (144)

1. Zuberbier T, Aberer W, Asero R etal. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy 2014; 69:868-87.
2. Maurer M, Weller K, Bindslev-Jensen C etal. Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 2011; 66:317-30.
3. Stitt JM, Dreskin SC. Urticaria and autoimmunity: where are we now? Curr Allergy Asthma Rep 2013; 13:555-62.
4. Bagnasco M, Minciullo PL, Saraceno GS, Gangemi S, Benvenga S. Urticaria and thyroid autoimmunity. Thyroid 2011; 21:401-10.
5. Napoli DC, Freeman TM. Autoimmunity in chronic urticaria and urticarial vasculitis. Curr Allergy Asthma Rep 2001; 1:329-36.
6. Konstantinou GN, Asero R, Ferrer M etal. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy 2013; 68:27-36.
7. Grattan CE, Boon AP, Eady RA, Winkelmann RK. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990; 93:198-204.
8. Lopes A, Machado D, Pedreiro S etal. Different frequencies of Tc17/Tc1 and Th17/Th1 cells in chronic spontaneous urticaria. Int Arch Allergy Immunol 2013; 161:155-62.
9. Atwa MA, Emara AS, Youssef N, Bayoumy NM. Serum concentration of IL-17, IL-23 and TNF-alpha among patients with chronic spontaneous urticaria: association with disease activity and autologous serum skin test. J Eur Acad Dermatol Venereol 2014; 28:469-74.
10. Chang TW, Chen C, Lin CJ, Metz M, Church MK, Maurer M. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria. J Allergy Clin Immunol 2015; 135(2):337-42.
11. Neverman L, Weinberger M. Treatment of chronic urticaria in children with antihistamines and cyclosporine. J Allergy Clin Immunol Pract 2014; 2:434-8.
12. O'Donnell BF, O'Neill CM, Francis DM etal. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999; 140:853-8.
13. Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin Exp Dermatol 2006; 31:424-9.
14. Cebeci F, Tanrikut A, Topcu E, Onsun N, Kurtulmus N, Uras AR. Association between chronic urticaria and thyroid autoimmunity. Eur J Dermatol 2006; 16:402-5.
15. Confino-Cohen R, Chodick G, Shalev V, Leshno M, Kimhi O, Goldberg A. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol 2012; 129:1307-13.
16. van Vollenhoven RF, Mosca M, Bertsias G etal. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014; 73:958-67.
17. Frieri M. Mechanisms of disease for the clinician: systemic lupus erythematosus. Ann Allergy Asthma Immunol 2013; 110:228-32.
18. Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol 1996; 135:355-62.
19. Kole AK, Ghosh A. Cutaneous manifestations of systemic lupus erythematosus in a tertiary referral center. Indian J Dermatol 2009; 54:132-6.
20. Gronhagen CM, Gunnarsson I, Svenungsson E, Nyberg F. Cutaneous manifestations and serological findings in 260 patients with systemic lupus erythematosus. Lupus 2010; 19:1187-94.
21. Rabbani MA, Shah SM, Ahmed A. Cutaneous manifestations of systemic lupus erythematosus in Pakistani patients. J Pak Med Assoc 2003; 53:539-41.
22. Drenkard C, Villa AR, Reyes E, Abello M, Alarcon-Segovia D. Vasculitis in systemic lupus erythematosus. Lupus 1997; 6:235-42.
23. Kapadia N, Haroon TS. Cutaneous manifestations of systemic lupus erythematosus: study from Lahore, Pakistan. Int J Dermatol 1996; 35:408-9.
24. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum 1991; 21:55-64.
25. Weinstein C, Miller MH, Axtens R, Littlejohn GO, Dorevitch AP, Buchanan R. Lupus and non-lupus cutaneous manifestations in systemic lupus erythematosus. Aust N Z J Med 1987; 17:501-6.
26. Provost TT, Zone JJ, Synkowski D, Maddison PJ, Reichlin M. Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions. Correlation with clinical and serological abnormalities. J Invest Dermatol 1980; 75:495-9.
27. Lee P, Urowitz MB, Bookman AA etal. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med 1977; 46:1-32.
28. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 1971; 50:85-95.
29. Dubois EL, Tuffanelli DL. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 1964; 190:104-11.
30. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954; 33:291-437.
31. Callen JP. Systemic lupus erythematosus in patients with chronic cutaneous (discoid) lupus erythematosus. Clinical and laboratory findings in seventeen patients. J Am Acad Dermatol 1985; 1:278-88.
32. Gilliam JN, Sontheimer RD. Skin manifestations of SLE. Clin Rheum Dis 1982; 8:207-18.
33. Zecevic RD, Vojvodic D, Ristic B, Pavlovic MD, Stefanovic D, Karadaglic D. Skin lesions-an indicator of disease activity in systemic lupus erythematosus? Lupus 2001; 10:364-7.
34. Wysenbeek AJ, Guedj D, Amit M, Weinberger A. Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non-cutaneous disease manifestations. Ann Rheum Dis 1992; 51:717-9.
35. Hawro T, Maurer M, Sysa-Jedrzejowska A, Wozniacka A. Prevalence of nonspecific cutaneous vascular lesions and association with antiphospholipid antibodies in patients with systemic lupus erythematosus. Br J Dermatol 2013; 168:213-5.
36. Sontheimer RD. The lexicon of cutaneous lupus erythematosus - a review and personal perspective on the nomenclature and classification of the cutaneous manifestations of lupus erythematosus. Lupus 1997; 6:84-95.
37. Cardinali C, Caproni M, Bernacchi E, Amato L, Fabbri P. The spectrum of cutaneous manifestations in lupus erythematosus - the Italian experience. Lupus 2000; 9:417-23.
38. Werth VP. Clinical manifestations of cutaneous lupus erythematosus. Autoimmun Rev 2005; 4:296-302.
39. Carneiro JR, Sato EI. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus. J Rheumatol 1999; 26:1275-9.
40. Pope J, Jerome D, Fenlon D, Krizova A, Ouimet J. Frequency of adverse drug reactions in patients with systemic lupus erythematosus. J Rheumatol 2003; 30:480-4.
41. de Moraes JC, Aikawa NE, Ribeiro AC etal. Immediate complications of 3, 555 injections of anti-TNFalpha. Rev Bras Reumatol 2010; 50:165-75.
42. Sonntag M, Lehmann P, Megahed M, Ruzicka T, Kuhn A. Lupus erythematosus tumidus in childhood. Report of 3 patients. Dermatology 2003; 207:188-92.
43. Kuhn A, Richter-Hintz D, Oslislo C, Ruzicka T, Megahed M, Lehmann P. Lupus erythematosus tumidus-a neglected subset of cutaneous Lupus erythematosus: report of 40 cases. Arch Dermatol 2000; 136:1033-41.
44. Saeb-Lima M, Charli-Joseph Y, Rodriguez-Acosta ED, Dominguez-Cherit J. Autoimmunity-related neutrophilic dermatosis: a newly described entity that is not exclusive of systemic lupus erythematosus. Am J Dermatopathol 2013; 35:655-60.
45. Holers VM. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus. J Clin Invest 2004; 114:616-9.
46. Berggren MA, Heinlen L, Isaksson A, Nystrom U, Ricksten A. EBNA1 expression in a lung transplant recipient with hypocomplementemic urticarial vasculitis syndrome. J Med Virol 2007; 79:963-9.
47. Frot AS, Barbarot S, Poignant S, Guyot C, Stalder JF. Angioedemes a evolution ecchymotique revelant un lupus erythemateux systemique de l'enfant avec anticorps anti-C1q [Ecchymotic angioedema revealing childhood systemic lupus erythematosus with anti-C1q antibodies]. Ann Dermatol Venereol 2008; 135:584-6.
48. Jachiet M, Flageul B, Deroux A etal. The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of 57 patients. Arthritis Rheumatol 2015; 67(2):527-34.
49. Llamas-Velasco M, Fraga J, Requena L, Sanchez-Perez J, Ovejero-Merino E, Garcia-Diez A. Urticaria con infiltrado inflamatorio de predominio neutrofilico o urticaria neutrofilica. Estudio de sus caracteristicas clinicas e histopatologicas y de su posible asociacion con enfermedad reumatologica [Neutrophilic urticaria or urticaria with predominantly neutrophilic inflammatory infiltrate: study of its clinical and histopathologic characteristics and its possible association with rheumatic disease]. Actas Dermosifiliogr 2012; 103:511-9.
50. Kieffer C, Cribier B, Lipsker D. Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine (Baltimore) 2009; 88:23-31.
51. Peters MS, Winkelmann RK. Neutrophilic urticaria. Br J Dermatol 1985; 113:25-30.
52. Horvath A, Kramer M, Ablonczy E. Clinical evaluation and pathomechanism of urticaria-like skin eruption in systemic lupus erythematosus. Acta Derm Venereol 1982; 62:253-6.
53. O'Loughlin S, Schroeter AL, Jordon RE. Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol 1978; 114:879-83.
54. Bader-Meunier B, Armengaud JB, Haddad E etal. Initial presentation of childhood-onset systemic lupus erythematosus: a French multicenter study. J Pediatr 2005; 146:648-53.
55. Spadoni M, Jacob C, Aikawa N, Jesus A, Fomin A, Silva C. Chronic autoimmune urticaria as the first manifestation of juvenile systemic lupus erythematosus. Lupus 2011; 20:763-6.
56. Dickey BZ, Holland KE, Drolet BA etal. Demographic and clinical characteristics of cutaneous lupus erythematosus at a paediatric dermatology referral centre. Br J Dermatol 2013; 169:428-33.
57. Wananukul S, Watana D, Pongprasit P. Cutaneous manifestations of childhood systemic lupus erythematosus. Pediatr Dermatol 1998; 15:342-6.
58. Ferriani MP, Silva MF, Pereira RM etal. Chronic spontaneous urticaria: a survey of 852 cases of childhood-onset systemic lupus erythematosus. Int Arch Allergy Immunol 2015; 167:186-92.
59. Jirapongsananuruk O, Pongpreuksa S, Sangacharoenkit P, Visitsunthorn N, Vichyanond P. Identification of the etiologies of chronic urticaria in children: a prospective study of 94 patients. Pediatr Allergy Immunol 2010; 21:508-14.
60. Du Toit G, Prescott R, Lawrence P etal. Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria. Ann Allergy Asthma Immunol 2006; 96:341-4.
61. Brunetti L, Francavilla R, Miniello VL etal. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004; 114:922-7.
62. Caffarelli C, Cuomo B, Cardinale F etal. Aetiological factors associated with chronic urticaria in children: a systematic review. Acta Derm Venereol 2013; 93:268-72.
63. Volonakis M, Katsarou-Katsari A, Stratigos J. Etiologic factors in childhood chronic urticaria. Ann Allergy 1992; 69:61-5.
64. Kilic G, Guler N, Suleyman A, Tamay Z. Chronic urticaria and autoimmunity in children. Pediatr Allergy Immunol 2010; 21:837-42.
65. Sackesen C, Sekerel BE, Orhan F, Kocabas CN, Tuncer A, Adalioglu G. The etiology of different forms of urticaria in childhood. Pediatr Dermatol 2004; 21:102-8.
66. Dodig S, Richter D. Chronic autoimmune urticaria in children. Acta Dermatovenerol Croat 2008; 16:65-71.
67. Cherrez Ojeda I, Cruz E, Leon R etal. Chronic autoimmune urticaria in children. Allergol Immunopathol (Madr) 2009; 37:43-7.
68. Matthews CN, Saihan EM, Warin RP. Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. Br J Dermatol 1978; 99:455-7.
69. Kutlu A, Ozturk S, Onem Y etal. Simple urticaria and systemic lupus erythematosus: why the(y) wait? Lupus 2010; 19:334.
70. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9:A277-87.
71. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000; 105:664-72.
72. Gaig P, Olona M, Munoz Lejarazu D etal. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004; 14:214-20.
73. Scott A, Rees EG. The relationship of systemic lupus erythematosus and discoid lupus erythematosus; a clinical and hematological study. AMA Arch Derm 1959; 79:422-35.
74. Grigor R, Edmonds J, Lewkonia R, Bresnihan B, Hughes GR. Systemic lupus erythematosus. A prospective analysis. Ann Rheum Dis 1978; 37:121-8.
75. Sherer Y, Gorstein A, Fritzler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2004; 34:501-37.
76. Pickering MC, Botto M. Are anti-C1q antibodies different from other SLE autoantibodies? Nat Rev Rheumatol 2010; 6:490-3.
77. Dema B, Pellefigues C, Hasni S etal. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS ONE 2014; 9:e90424.
78. Gatto M, Zen M, Ghirardello A etal. Emerging and critical issues in the pathogenesis of lupus. Autoimmun Rev 2013; 12:523-36.
79. Schroeder K, Herrmann M, Winkler TH. The role of somatic hypermutation in the generation of pathogenic antibodies in SLE. Autoimmunity 2013; 46:121-7.
80. Kalaaji M, Fenton KA, Mortensen ES etal. Glomerular apoptotic nucleosomes are central target structures for nephritogenic antibodies in human SLE nephritis. Kidney Int 2007; 71:664-72.
81. Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009; 64:1256-68.
82. Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria - a clinical, immunological and histological evaluation. Br J Dermatol 1986; 114:583-90.
83. Fiebiger E, Hammerschmid F, Stingl G, Maurer D. Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998; 101:243-51.
84. Cho CB, Stutes SA, Altrich ML, Ardoin SP, Phillips G, Ogbogu PU. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders. Ann Allergy Asthma Immunol 2013; 110:29-33.
85. Gruber BL, Kaufman LD, Marchese MJ, Roth W, Kaplan AP. Anti-IgE autoantibodies in systemic lupus erythematosus. Prevalence and biologic activity. Arthritis Rheum 1988; 31:1000-6.
86. Altrichter S, Peter HJ, Pisarevskaja D, Metz M, Martus P, Maurer M. IgE mediated autoallergy against thyroid peroxidase - a novel pathomechanism of chronic spontaneous urticaria? PLoS ONE 2011; 6:e14794.
87. Hatada Y, Kashiwakura J, Hayama K etal. Significantly high levels of anti-dsDNA immunoglobulin E in sera and the ability of dsDNA to induce the degranulation of basophils from chronic urticaria patients. Int Arch Allergy Immunol 2013; 161(Suppl. 2):154-8.
88. Concha LB, Chang CC, Szema AM, Dattwyler RJ, Carlson HE. IgE antithyroid antibodies in patients with Hashimoto's disease and chronic urticaria. Allergy Asthma Proc 2004; 25:293-6.
89. Atta AM, Sousa CP, Carvalho EM, Sousa-Atta ML. Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res 2004; 37:1497-501.
90. Sekigawa I, Yoshiike T, Iida N, Hashimoto H, Ogawa H. Allergic diseases in systemic lupus erythematosus: prevalence and immunological considerations. Clin Exp Rheumatol 2003; 21:117-21.
91. Wozniacka A, Sysa-Jedrzejowska A, Robak E, Samochocki Z, Zak-Prelich M. Allergic diseases, drug adverse reactions and total immunoglobulin E levels in lupus erythematosus patients. Mediators Inflamm 2003; 12:95-9.
92. Charles N, Hardwick D, Daugas E, Illei GG, Rivera J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 2010; 16:701-7.
93. Atta AM, Santiago MB, Guerra FG, Pereira MM, Sousa Atta ML. Autoimmune response of IgE antibodies to cellular self-antigens in systemic Lupus Erythematosus. Int Arch Allergy Immunol 2010; 152:401-6.
94. Permin H, Wiik A. The prevalence of IgE antinuclear antibodies in rheumatoid arthritis and systemic lupus erythematosus. Acta Pathol Microbiol Scand C 1978; 86C:245-9.
95. Namboodiri MS, Nagpal S, Rao PV. Induction of anti-DNA IgG and IgE antibodies in BALB/c mice. J Autoimmun 1992; 5:653-63.
96. Rodriguez Gomez M, Talke Y, Goebel N, Hermann F, Reich B, Mack M. Basophils support the survival of plasma cells in mice. J Immunol 2010; 185:7180-5.
97. Tuma SN, Llach F, Sostrin S, Dubois EL, Massry SG. Glomerular IgE deposits in patients with lupus nephritis. Am J Nephrol 1981; 1:31-6.
98. Kojima K, Sasaki A, Yokomatsu Y etal. Deficiency of the seventh component of complement with systemic lupus erythematosus. Osaka City Med J 1985; 31:121-8.
99. Ballanti E, Perricone C, Greco E etal. Complement and autoimmunity. Immunol Res 2013; 56:477-91.
100. Kikuchi Y, Kaplan AP. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol 2002; 109:114-8.
101. Marsland AM. Autoimmunity and complement in the pathogenesis of chronic urticaria. Curr Allergy Asthma Rep 2006; 6:265-9.
102. Kotnik V. Complement in skin diseases. Acta Dermatovenerol Alp Pannonica Adriat 2011; 20:3-11.
103. Garmendia JV, Munoz LE, Zabaleta M, Tassinari P, Bianco NE. Anti-C1q antibodies in patients with chronic idiopathic urticaria. J Allergy Clin Immunol 2014; 113(2 Suppl.):S25-438.
104. Tedeschi A, Kolkhir P, Asero R etal. Chronic urticaria and coagulation: pathophysiological and clinical aspects. Allergy 2014; 69:683-91.
105. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117:1113-7.
106. Zhu H, Liang B, Li R etal. Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 2013; 31:43-50.
107. Levi M, van der Poll T. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15:254-9.
108. Huber-Lang M, Sarma JV, Zetoune FS etal. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med 2006; 12:682-7.
109. Katayama I, Matsui S, Murota H. Platelet activation as a possible indicator of disease activity in chronic urticaria: link with blood coagulation and mast cell degranulation. J Clin Exp Dermatol Res 2013; 4:194.
110. Spring P, Angelillo-Scherrer A, Bigliardi P. Chronic idiopathic urticaria successfully treated by anticoagulant drugs. Eur J Dermatol 2012; 22:788-90.
111. Nasonova VA, Saikovskaia TV. Vnutrisosudistoe svertyvanie krovi i immunokompleksnoe vospalenie u bol'nykh sistemnoi krasnoi volchankoi [Intravascular blood coagulation and immune complex inflammation in patients with systemic lupus erythematosus]. Ter Arkh 1985; 57:91-8.
112. Zuily S, Ait Aissa K, Membre A, Regnault V, Lecompte T, Wahl D. Thrombin generation in antiphospholipid syndrome. Lupus 2012; 21:758-60.
113. Cugno M, Asero R, Tedeschi A, Lazzari R, Marzano AV. Inflammation and coagulation in urticaria and angioedema. Curr Vasc Pharmacol 2012; 10:653-8.
114. Pereira J, Alfaro G, Goycoolea M etal. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state. Thromb Haemost 2006; 95:94-9.
115. Sweiss NJ, Bo R, Kapadia R etal. IgA anti-beta2-glycoprotein I autoantibodies are associated with an increased risk of thromboembolic events in patients with systemic lupus erythematosus. PLoS ONE 2010; 5:e12280.
116. Mehrani T, Petri M. Association of IgA Anti-beta2 glycoprotein I with clinical and laboratory manifestations of systemic lupus erythematosus. J Rheumatol 2011; 38:64-8.
117. Fujii K, Usuki A, Kan-No Y, Ohgou N. Elevation of circulating thrombin-antithrombin III complex and fibrin degradation products in urticaria: a laboratory finding unrelated to intravascular coagulopathy. J Dermatol 2008; 35:308-10.
118. Magen E, Mishal J, Zeldin Y etal. Increased mean platelet volume and C-reactive protein levels in patients with chronic urticaria with a positive autologous serum skin test. Am J Med Sci 2010; 339:504-8.
119. Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115:3378-84.
120. Milovanovic M, Nilsson E, Jaremo P. Relationships between platelets and inflammatory markers in rheumatoid arthritis. Clin Chim Acta 2004; 343:237-40.
121. Yavuz S, Ece A. Mean platelet volume as an indicator of disease activity in juvenile SLE. Clin Rheumatol 2014; 33:637-41.
122. Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: mean platelet volume reflects disease activity. Platelets 2010; 21:122-5.
123. Kisacik B, Tufan A, Kalyoncu U etal. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008; 75:291-4.
124. Bhattarai S, Agrawal S, Rijal A, Sharma SK, Dhakal SS. Spectrum of cutaneous manifestations in lupus erythematous -a dermatologist perspective. Health Renaissance 2012; 10:8-11.
125. Das NK, Dutta RN, Sengupta SR. Skin lesions in lupus erythematosus: a marker of systemic involvement. Indian J Dermatol 2011; 56:537-40.
126. Fathi H, Ahmed EF, Abdelgawad MM, ElBayoumi Y. Cutaneous manifestations of systemic lupus erythematosus: a retrospective study from Egypt. Gulf J Dermatol Venereol 2010; 17:36-42.
127. Mowla MR, Alam M, Hoque MG etal. The spectrum of cutaneous manifestations in lupus erythematosus: the tretiary hospital experience. JCMCTA 2010; 21:34-9.
128. Koskenmies S, Jarvinen TM, Onkamo P etal. Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. Lupus 2008; 17:337-47.
129. Hau KL. Cutaneous manifestations of systemic lupus erythematosus. Hong Kong J Dermatol Venereol 2006; 14:120-8.
130. Morton S, Palmer B, Muir K, Powell RJ. IgE and non-IgE mediated allergic disorders in systemic lupus erythematosus. Ann Rheum Dis 1998; 57:660-3.
131. Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR. Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features. Semin Arthritis Rheum 1992; 21:221-6.
132. Parks CG, Biagini RE, Cooper GS, Gilkeson GS, Dooley MA. Total serum IgE levels in systemic lupus erythematosus and associations with childhood onsetallergies. Lupus 2010; 19:1614-22.
133. Nazarinia MA, Ghaffarpasand F, Shamsdin A, Karimi AA, Abbasi N, Amiri A. Systemic lupus erythematosus in the Fars Province of Iran. Lupus 2008; 17:221-7.
134. Bouaziz JD, Barete S, Le Pelletier F, Amoura Z, Piette JC, Frances C. Cutaneous lesions of the digits in systemic lupus erythematosus: 50 cases. Lupus 2007; 16:163-7.
135. Ramos-Casals M, Nardi N, Lagrutta M etal. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 2006; 85:95-104.
136. Worrall JG, Snaith ML, Batchelor JR, Isenberg DA. SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. Q J Med 1990; 74:319-30.
137. Tan EM, Cohen AS, Fries JF etal. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
138. Biazar C, Sigges J, Patsinakidis N etal. Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE). Autoimmun Rev 2013; 12:444-54.
139. Iqbal S, Sher MR, Good RA, Cawkwell GD. Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 1999; 135:500-5.
140. Vitali C, Doria A, Tincani A etal. International survey on the management of patients with SLE. I. General data on the participating centers and the results of a questionnaire regarding mucocutaneous involvement. Clin Exp Rheumatol 1996; 14(Suppl. 16):S17-22.
141. Al-Attia HM, Al Ahmed YH. Mucocutaneous disease in Arabs with systemic lupus erythematosus: clinical expression and relevance to autoantibodies. Lupus 1998; 7:535-9.
142. Beutner EH, Jablonska S, White DB etal. Dermatologic criteria for classifying the major forms of cutaneous lupus erythematosus: methods for systematic discriminant analysis and questions on the interpretation of findings. Clin Dermatol 1992; 10:443-56.
143. Hendrix R. Klinische analytische studie van 28 gevallen van lupus erythematodus disseminatus [Clinical analytical study of 28 cases of disseminated lupus erythematosus]. Acta Clin Belg 1973; 28:69-91.
144. Becker LC. Allergy in systemic lupus erythematosus. Johns Hopkins Med J 1973; 133:38-44.